Chromogenex Limited joins share matching facility on 27th October following their de-listing from the Aim market in April 2009
Chromogenex PLC is the UK’s leading developer and manufacturer of laser and intense pulsed light (IPL) systems.
Since 1985, Chromogenex PLC has been at the forefront of laser and light technology for aesthetic applications such as hair removal, skin rejuvenation, acne and vascular lesions.
In 1994, the company developed and patented the world’s first Ruby laser for permanent hair reduction.
In 1998, we introduced the patented Nlite laser, the first laser to receive FDA clearance for wrinkle reduction and in 2000 we were the first company to receive FDA Approval for Inflammatory acne vulgaris, working with some of the world’s leading Dermatologists and Clinical Researchers.
J P Jenkins is part of Rivington Street Holdings.
Rivington Street Corporate Finance is regulated by the Financial Services Authority and is a PLUS Corporate Adviser Member.